美国膀胱癌根治性膀胱切除术后再入院的多水平分析:医院因素是否重要
基于美国全国再入院数据库2014年数据,纳入341家医院7095例加权样本的根治性膀胱切除术患者,30天再入院率为29.5%(95%CI 27.8-31.2%)。多水平混合效应模型显示,在控制患者特征后,医院层面随机效应仅解释极少的再入院变异(伪R²<0.01%),医院手术量、床位规模、所有权和教学状态与再入院率无显著关联。
要点
- 根治性膀胱切除术后30天再入院率为29.5%(95%CI 27.8-31.2%)。
- 医院间再入院率差异大,最低四分位为1.4%,最高为73.6%。
- 控制患者特征后,医院层面效应仅解释极少的再入院变异。
核心结论
- 调整患者特征后,医院层面效应仅解释医院间再入院率巨大变异的很小部分。
- 这些发现强调将术后30天再入院作为医院质量指标的局限性。
研究设计与样本
- 研究识别2014年美国全国再入院数据库(NRD)中接受根治性膀胱切除术的个体,NRD为全国代表性、全支付方数据库,包含索引医院和非索引医院的再入院。
- 使用调查权重生成全国估计,采用多水平混合效应模型估计患者和医院特征与再入院的统计关联。
- 加权样本为7095例在341家美国医院接受根治性膀胱切除术的个体。
主要发现
- 30天再入院率为29.5%(95%CI 27.8-31.2%),范围从最低四分位的1.4%(95%CI 0.6-2.2%)到最高四分位的73.6%(95%CI 68.4-78.7)。
- 在多水平模型中,女性性别和合并症评分与再入院可能性较高相关。
- 医院随机效应项在患者特征保持人群均值不变时对再入院模型贡献极小(医院效应伪R²<0.01%)。
- 将手术量、床位规模、医院所有权和教学状态加入模型后,这些因素与再入院率无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospitals are increasingly being held responsible for their readmissions rates. The contribution of hospital versus patient factors (eg, case mix) to hospital readmissions is unknown. OBJECTIVE: To estimate the relative contribution of hospital and patient factors to readmissions after radical cystectomy (RC) for bladder cancer. DESIGN, SETTING, AND PARTICIPANTS: We identified individuals who underwent RC in 2014 in the Nationwide Readmissions Database (NRD). The NRD is a nationally representative (USA), all-payer database that includes readmissions at index and nonindex hospitals. Survey weights were used to generate national estimates. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The main outcome was readmission within 30 d after RC. Using a multilevel mixed-effects model, we estimated the statistical association between patient and hospital characteristics and readmission. A hospital-level random-effects term was used to estimate hospital-level readmission rates while holding patient characteristics constant. RESULTS AND LIMITATIONS: We identified a weighted sample of 7095 individuals who underwent RC at 341 hospitals in the USA. The 30-d readmission rate was 29.5% (95% confidence interval [CI] 27.8-31.2%), ranging from 1.4% (95% CI 0.6-2.2%) in the bottom quartile to 73.6% (95% CI 68.4-78.7) in the top. In our multilevel model, female sex and comorbidity score were associated with a higher likelihood of readmission. The hospital random-effects term, encompassing both measured and unmeasured hospital characteristics, contributed minimally to the model for readmission when patient characteristics were held constant at population mean values (pseudo-R2<0.01% for hospital effects). Surgical volume, bed size, hospital ownership, and academic status were not significantly associated with readmission rates when these terms were added to the model. CONCLUSIONS: After adjusting for patient characteristics, hospital-level effects explained little of the large between-hospital variability in readmission rates. These findings underscore the limitations of using 30-d post-discharge readmissions as a hospital quality metric. PATIENT SUMMARY: The chance of being readmitted after radical cystectomy varies substantially between hospitals. Little of this variability can be explained by hospital-level characteristics, while far more can be explained by patient characteristics and random variability.
引用
- Cole AP, Ramaswamy A, Harmouch S, et al. Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference? Eur Urol Oncol. 2018. PMID: 31277772. doi:10.1016/j.euo.2018.08.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。